A Unique Approach To

Neurological & Mental Illness

We aim to transform the lives of patients with neurological and psychiatric disorders.

THERAPEUTICS

We are advancing a diversified portfolio that includes multiple novel therapeutics.

Terran Biosciences Pipeline
IMAGING SOFTWARE DEVICE

Our software as a medical device (SaMD) program plays an important role in our smart clinical trial platform and presents multiple independent opportunities to transform the current standard of patient care.

TEAM

Our unique approach is pioneered by our visionary team.

Sam Clark Terran Biosciences CEO

Samuel Clark, MD, PhD

Chief Executive Officer (CEO)

Dustin Tetzl Terran Biosciences CBO

Dustin Tetzl, MD

Chief Business Officer (CBO)

Anissa Abi-Dargham, MD

Anissa Abi-Dargham, MD

Vice Chair of Research, Psychiatry Stony Brook University

John Krystal, MD

John Krystal, MD

Chair of Psychiatry, Yale University

Jerry Rosenbaum, MD

Jerry Rosenbaum, MD

Chief of Psychiatry, Massachusetts General Hospital

David Rubinow, MD

David Rubinow, MD

Former Chair of Psychiatry, University of North Carolina Chapel Hill

Robert Litman, MD

Robert Litman, MD

Associate Professor of Psychiatry at Georgetown University

John M. Kane, MD

John M. Kane, MD

Chair & Professor, Psychiatry, Zucker School of Medicine at Hofstra/Northwell

Robert Post, MD

Robert Post, MD

Head of the Bipolar Collaborative Network

Mark Slifstein, PhD

Mark Slifstein, PhD

Director of the PET Research Core, Stony Brook University

Christoph Kellendonk, PhD

Christoph Kellendonk, PhD

Professor of Pharmacology in Psychiatry, Columbia University

Scott Thompson, PhD

Scott Thompson, PhD

Chair, Dept. of Physiology, University of Maryland, Baltimore, School of Medicine

Qin Wang, MD, PhD

Qin Wang, MD, PhD

Professor, Dept. Cell, Developmental and Integrative Biology, Univ. of Alabama at Birmingham

Contact Us